The Patent Finder

MG Pharma Inc.

Also on record
Records under this name other than patents MG Pharma Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.

Showing 1 to 7 of 7 · Back to MG Pharma Inc.

PatentTitleStatus Expires Confidence
US 8,691,949Peptide having anti-diabetic activity and use thereof
Lapsed on the fee record
Ended Apr 8, 2022 · From the USPTO record
Lapsed on the fee recordEnded Apr 8, 2022From the USPTO record
US 8,394,769Anti-hypertensive agent
Lapsed on the fee record
Ended Mar 12, 2021 · From the USPTO record
Lapsed on the fee recordEnded Mar 12, 2021From the USPTO record
US 8,357,776Composition for suppressing re-elevation of cholesterol, and usage thereof
Lapsed on the fee record
Ended Jan 22, 2021 · From the USPTO record
Lapsed on the fee recordEnded Jan 22, 2021From the USPTO record
US 6,046,168Peptide inhibits blood triglyceride level
Lapsed on the fee record
Ended Apr 4, 2012 · From the USPTO record
Lapsed on the fee recordEnded Apr 4, 2012From the USPTO record
US 5,723,443Lipid metabolism promoting agent and its use
Term ended
Term ended no later than Mar 3, 2018 · Low confidence
Term endedTerm ended no later than Mar 3, 2018Low confidence
US 5,756,467Adipocyte differentiation inhibiting peptide and adipocyte differentiation inhibiting agent using the peptide as active component thereof
Term ended
Term ended no later than May 26, 2018 · Low confidence
Term endedTerm ended no later than May 26, 2018Low confidence
US 5,958,885Peptide and formulations thereof inhibiting elevations of triglyceride levels in blood
Formerly held
Term ended
Term ended no later than Sep 28, 2019 · Low confidence
Term endedTerm ended no later than Sep 28, 2019Low confidence
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 15, 2026 · includes USPTO assignment & status data published Nov 15, 2026 and grant & fee data published Nov 10, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited